Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

 VYGR – Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc.
VYGR
$3.43
Name : Voyager Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $189,527,168.00
EPSttm : -1.46
finviz dynamic chart for VYGR
Voyager Therapeutics, Inc.
$3.43
3.79%
$0.125

Float Short %

6.25

Margin Of Safety %

Put/Call OI Ratio

0.18

EPS Next Q Diff

EPS Last/This Y

-0.96

EPS This/Next Y

0.47

Price

3.3

Target Price

15.78

Analyst Recom

1.08

Performance Q

-20.29

Relative Volume

1.15

Beta

0.82

Ticker: VYGR




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-05-07VYGR3.290.390.001262
2025-05-08VYGR3.430.380.001272
2025-05-09VYGR3.180.380.171279
2025-05-12VYGR3.350.380.631286
2025-05-13VYGR3.290.390.001316
2025-05-14VYGR3.20.390.201316
2025-05-15VYGR3.280.390.001319
2025-05-16VYGR3.30.390.001327
2025-05-19VYGR3.420.300.001127
2025-05-20VYGR3.40.290.001147
2025-05-21VYGR3.140.290.001163
2025-05-22VYGR2.970.290.001163
2025-05-23VYGR2.910.280.211184
2025-05-27VYGR2.810.290.001191
2025-05-28VYGR2.730.290.051196
2025-05-29VYGR2.810.280.001229
2025-05-30VYGR2.740.2810.001240
2025-06-02VYGR3.30.330.101295
2025-06-03VYGR3.280.220.112666
2025-06-04VYGR3.320.200.032757
2025-06-05VYGR3.30.180.013134
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-05-07VYGR3.28-119.4- -1.62
2025-05-08VYGR3.42-119.4- -1.62
2025-05-09VYGR3.17-119.4- -2.08
2025-05-12VYGR3.35-119.4- -2.08
2025-05-13VYGR3.28-159.5- -2.08
2025-05-14VYGR3.19-159.5- -2.08
2025-05-15VYGR3.28-159.5- -2.08
2025-05-16VYGR3.29-159.5- -2.08
2025-05-19VYGR3.43-190.6- -2.09
2025-05-20VYGR3.40-190.6- -2.09
2025-05-21VYGR3.14-190.6- -2.09
2025-05-22VYGR2.97-190.6- -2.09
2025-05-23VYGR2.91-190.6- -2.09
2025-05-27VYGR2.82-190.6- -2.09
2025-05-28VYGR2.73-190.6- -2.09
2025-05-29VYGR2.81-190.6- -2.09
2025-05-30VYGR2.74-190.6- -2.09
2025-06-02VYGR3.31-190.6- -2.09
2025-06-03VYGR3.28-190.6- -2.09
2025-06-04VYGR3.32-190.6- -2.09
2025-06-05VYGR3.30-190.6- -2.09
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-05-07VYGR-0.81-14.436.67
2025-05-08VYGR-0.81-14.436.67
2025-05-09VYGR-0.81-14.436.67
2025-05-12VYGR-0.81-7.506.44
2025-05-13VYGR-0.81-7.506.44
2025-05-14VYGR-0.81-7.506.44
2025-05-15VYGR-0.81-7.506.44
2025-05-16VYGR-0.81-7.506.44
2025-05-19VYGR-0.81-9.396.44
2025-05-20VYGR-0.81-9.396.44
2025-05-21VYGR-0.81-9.396.44
2025-05-22VYGR-0.81-9.396.44
2025-05-23VYGR-0.81-9.396.44
2025-05-27VYGR-0.81-0.926.44
2025-05-28VYGR-0.81-0.926.25
2025-05-29VYGR-0.81-0.926.25
2025-05-30VYGR-0.81-0.926.25
2025-06-02VYGR-0.810.426.25
2025-06-03VYGR-0.810.426.25
2025-06-04VYGR-0.810.426.25
2025-06-05VYGR-0.810.426.25
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

-0.53

Avg. EPS Est. Current Quarter

-0.52

Avg. EPS Est. Next Quarter

-0.53

Insider Transactions

-0.81

Institutional Transactions

0.42

Beta

0.82

Average Sales Estimate Current Quarter

9

Average Sales Estimate Next Quarter

9

Fair Value

Quality Score

21

Growth Score

40

Sentiment Score

79

Actual DrawDown %

77.4

Max Drawdown 5-Year %

-82.6

Target Price

15.78

P/E

Forward P/E

PEG

P/S

2.73

P/B

0.67

P/Free Cash Flow

EPS

-1.46

Average EPS Est. Cur. Y​

-2.09

EPS Next Y. (Est.)

-1.62

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-126.49

Relative Volume

1.15

Return on Equity vs Sector %

-55.1

Return on Equity vs Industry %

-37.2

EPS 1 7Days Diff

-0.5

EPS 1 30Days Diff

-0.47

EBIT Estimation

Voyager Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 172
Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. The company's lead product candidate is VY7523, an anti-tau antibody program for the treatment of alzheimer's disease (AD). Its product pipeline includes VY1706, a tau silencing gene therapy in preclinical trial for the treatment of alzheimer's disease; SOD1 silencing gene therapy program for treating amyotrophic lateral sclerosis in preclinical trial; and vectorized anti-amyloid antibody early research program for the treatment of AD in preclinical trial. The company is also developing VY-FXN01 for treating friedreich's ataxia; and GBA1 gene replacement program to treat parkinson's disease. In addition, it provides research program for the treatment of Huntington's disease. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Neurocrine Biosciences, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.
stock quote shares  VYGR – Voyager Therapeutics, Inc. Stock Price stock today
news today  VYGR – Voyager Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch  VYGR – Voyager Therapeutics, Inc. yahoo finance google finance
stock history  VYGR – Voyager Therapeutics, Inc. invest stock market
stock prices VYGR premarket after hours
ticker VYGR fair value insiders trading